Onconetix, Inc. SEC filings ONCO
Onconetix, Inc. has 398 filings in SEC EDGAR's recent list, going back to Jul 15, 2019. Its latest annual report, Form ARS, was filed on Oct 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 425 | Current report | Nov 6, 2026 | — |
| 8-K |
Current report
Material agreement
|
Nov 6, 2026 | Nov 4, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2026 | — |
| 425 | Form 425 | Oct 27, 2026 | — |
| 8-K |
Current report
Other events
|
Oct 26, 2026 | Oct 22, 2026 |
| DEFA14A | Additional proxy material | Oct 23, 2026 | — |
| 8-K |
Current report
Other events
|
Oct 23, 2026 | Oct 22, 2026 |
| 425 | Form 425 | Oct 23, 2026 | — |
| ARS | Annual report to shareholders | Oct 16, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Oct 7, 2026 | Nov 10, 2026 |
| PRE 14A | Preliminary proxy statement | Sep 17, 2026 | Sep 17, 2026 |
| DEFA14A | Additional proxy material | Sep 14, 2026 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 14, 2026 | Sep 11, 2026 |
| 425 | Form 425 | Sep 14, 2026 | — |
| 424B3 | Prospectus | Sep 8, 2026 | — |
| EFFECT | Filing | Sep 3, 2026 | — |
| 425 | Form 425 | Sep 3, 2026 | — |
| S-1/A | Amended registration statement | Aug 31, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| S-1 | Registration statement | Aug 12, 2026 | — |
| 425 | Form 425 | Aug 6, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jul 29, 2026 | Jul 28, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 27, 2026 | — |
| 425 | Form 425 | Jul 7, 2026 | — |
| 425 | Form 425 | Jun 24, 2026 | — |
| 424B3 | Prospectus | Jun 17, 2026 | — |
| EFFECT | Filing | Jun 16, 2026 | — |
| CORRESP | Letter to the SEC | Jun 15, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2026 | — |
| S-1 | Registration statement | Jun 9, 2026 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
May 19, 2026 | May 19, 2026 |
| 8-K |
Current report
Other events
|
May 14, 2026 | May 13, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 424B3 | Prospectus | May 12, 2026 | — |
| EFFECT | Filing | May 11, 2026 | — |
| EFFECT | Filing | May 7, 2026 | — |
| S-1/A | Amended registration statement | May 7, 2026 | — |
| CORRESP | Letter to the SEC | May 7, 2026 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | May 7, 2026 | — |
| UPLOAD | Letter from the SEC | May 5, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
May 4, 2026 | Apr 30, 2026 |
| S-1 | Registration statement | Apr 28, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Apr 24, 2026 | Apr 20, 2026 |
| 4 | Insider transaction | Apr 22, 2026 | Apr 14, 2026 |
| 4 | Insider transaction | Apr 21, 2026 | Apr 14, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 14, 2026 |
| 3 | Initial insider ownership | Apr 16, 2026 | Apr 14, 2026 |
| 425 | Form 425 | Apr 9, 2026 | — |
| 425 | Form 425 | Apr 2, 2026 | — |
| 425 | Form 425 | Mar 31, 2026 | — |
| DEF 14A | Proxy statement | Mar 30, 2026 | Apr 30, 2026 |
| 3 | Initial insider ownership | Mar 27, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 27, 2026 | Mar 19, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Mar 27, 2026 | Mar 23, 2026 |
| 425 | Form 425 | Mar 25, 2026 | — |
| 8-K/A |
Amended current report
Officer or director change
|
Mar 25, 2026 | Mar 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 24, 2026 | Mar 18, 2026 |
| PRE 14A | Preliminary proxy statement | Mar 18, 2026 | Apr 30, 2026 |
| 10-K | Annual report | Mar 13, 2026 | Dec 31, 2025 |
| 425 | Current report | Feb 12, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Feb 12, 2026 | Feb 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Feb 9, 2026 | Feb 3, 2026 |
| DEF 14A | Proxy statement | Jan 2, 2026 | Feb 3, 2026 |
| EFFECT | Filing | Dec 23, 2025 | — |
| 424B3 | Prospectus | Dec 23, 2025 | — |
| CORRESP | Letter to the SEC | Dec 22, 2025 | — |
| PRE 14A | Preliminary proxy statement | Dec 22, 2025 | Dec 22, 2025 |
| S-1/A | Amended registration statement | Dec 22, 2025 | — |
| 3 | Initial insider ownership | Dec 12, 2025 | Dec 5, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Dec 10, 2025 | Dec 5, 2025 |
| 8-K |
Current report
Material agreement
|
Dec 10, 2025 | Dec 6, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 424B3 | Prospectus | Nov 10, 2025 | — |
| DEF 14A | Proxy statement | Nov 10, 2025 | Dec 5, 2025 |
| S-1 | Registration statement | Nov 4, 2025 | — |
| 8-K | Current report | Oct 29, 2025 | Oct 23, 2025 |
| PRE 14A | Preliminary proxy statement | Oct 29, 2025 | Oct 28, 2025 |
| S-1 | Registration statement | Oct 16, 2025 | — |
| D | Filing | Oct 7, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 3, 2025 | Oct 1, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure
|
Sep 26, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 22, 2025 | Sep 17, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 4, 2025 | Aug 28, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, New debt, Officer or director change
|
Aug 12, 2025 | Aug 6, 2025 |
| 4 | Insider transaction | Jul 16, 2025 | Jul 14, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jul 16, 2025 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Other events
|
Jul 16, 2025 | Jul 16, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 16, 2025 | Jun 16, 2025 |
| 10-Q | Quarterly report | Jun 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Material agreement, New debt, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Jun 11, 2025 | Jun 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2025 | May 30, 2025 |
| 10-K | Annual report | Jun 2, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, New debt, Listing notice
|
May 22, 2025 | May 16, 2025 |
| UPLOAD | Letter from the SEC | May 2, 2025 | — |
| 8-K |
Current report
Listing notice
|
Apr 30, 2025 | Apr 24, 2025 |
| DEF 14A | Proxy statement | Apr 30, 2025 | May 30, 2025 |
| PRER14A | Revised preliminary proxy statement | Apr 28, 2025 | — |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Apr 18, 2025 |
| 8-K |
Current report
Listing notice, Other events
|
Apr 18, 2025 | Apr 14, 2025 |
| 8-K |
Current report
Other events
|
Apr 8, 2025 | Apr 8, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 3, 2025 | Mar 28, 2025 |
| NT 10-K | Notification of late filing | Apr 1, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 25, 2025 | Mar 23, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2025 | Mar 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 19, 2025 | Mar 19, 2025 |
| 3 | Initial insider ownership | Mar 7, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Feb 28, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Material agreement, New debt, Auditor change, Officer or director change
|
Feb 18, 2025 | Feb 12, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 14, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| 424B3 | Prospectus | Feb 12, 2025 | — |
| EFFECT | Filing | Feb 11, 2025 | — |
| CORRESP | Letter to the SEC | Feb 10, 2025 | — |
| S-1/A | Amended registration statement | Feb 7, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 7, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2025 | — |
| S-1 | Registration statement | Jan 27, 2025 | — |
| 8-K |
Current report
Listing notice
|
Jan 24, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Other events
|
Jan 22, 2025 | Jan 15, 2025 |
| 4 | Insider transaction | Jan 22, 2025 | Dec 20, 2024 |
| 4 | Insider transaction | Jan 22, 2025 | Dec 20, 2024 |
| 424B3 | Prospectus | Dec 17, 2024 | — |
| EFFECT | Filing | Dec 12, 2024 | — |
| 8-K |
Current report
Listing notice, Other events
|
Dec 12, 2024 | Dec 6, 2024 |
| CORRESP | Letter to the SEC | Dec 11, 2024 | — |
| S-1/A | Amended registration statement | Dec 11, 2024 | — |
| S-8 | Employee stock plan registration | Dec 11, 2024 | — |
| S-1/A | Amended registration statement | Dec 10, 2024 | — |
| 10-Q | Quarterly report | Dec 10, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Material agreement
|
Dec 3, 2024 | Nov 26, 2024 |
| NT 10-Q | Notification of late filing | Nov 15, 2024 | Sep 30, 2024 |
| 424B4 | Prospectus | Nov 15, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 14, 2024 | — |
| EFFECT | Filing | Nov 12, 2024 | — |
| CORRESP | Letter to the SEC | Nov 12, 2024 | — |
| S-1/A | Amended registration statement | Nov 12, 2024 | — |
| CORRESP | Letter to the SEC | Nov 12, 2024 | — |
| CORRESP | Letter to the SEC | Nov 12, 2024 | — |
| CORRESP | Letter to the SEC | Nov 12, 2024 | — |
| S-1/A | Amended registration statement | Nov 12, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 7, 2024 | — |
| S-1 | Registration statement | Nov 1, 2024 | — |
| S-1 | Registration statement | Nov 1, 2024 | — |
| 3/A | Filing | Nov 1, 2024 | Sep 24, 2024 |
| DEF 14C | Information statement | Oct 31, 2024 | Nov 1, 2024 |
| 8-K |
Current report
Auditor change
|
Oct 21, 2024 | Oct 15, 2024 |
| PRE 14C | Preliminary information statement | Oct 18, 2024 | Oct 18, 2024 |
| D | Filing | Oct 17, 2024 | — |
| 8-K/A |
Amended current report
Listing notice, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Oct 9, 2024 | Sep 18, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Oct 3, 2024 | Oct 2, 2024 |
| SC 13D | Ownership over 5% (active) | Oct 1, 2024 | — |
| SC 13D | Ownership over 5% (active) | Oct 1, 2024 | — |
| 4 | Insider transaction | Sep 30, 2024 | Sep 26, 2024 |
| 4 | Insider transaction | Sep 30, 2024 | Sep 26, 2024 |
| 4 | Insider transaction | Sep 30, 2024 | Sep 26, 2024 |
| 4 | Insider transaction | Sep 30, 2024 | Sep 26, 2024 |
| 4 | Insider transaction | Sep 30, 2024 | Sep 26, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Sep 27, 2024 | — |
| 3 | Initial insider ownership | Sep 26, 2024 | Sep 24, 2024 |
| SC 13D | Ownership over 5% (active) | Sep 26, 2024 | — |
| 4 | Insider transaction | Sep 26, 2024 | Sep 24, 2024 |
| 4 | Insider transaction | Sep 26, 2024 | Sep 24, 2024 |
| SC 13G | Ownership over 5% (passive) | Sep 26, 2024 | — |
| 8-K |
Current report
Listing notice, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Sep 24, 2024 | Sep 18, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 20, 2024 | Sep 19, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 20, 2024 | Sep 20, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Sep 11, 2024 | Sep 5, 2024 |
| 8-K |
Current report
Other events
|
Sep 5, 2024 | Sep 4, 2024 |
| DEFA14A | Additional proxy material | Sep 3, 2024 | — |
| 8-K |
Current report
Other events
|
Sep 3, 2024 | Sep 3, 2024 |
| 10-Q | Quarterly report | Aug 29, 2024 | Jun 30, 2024 |
| NT 10-Q | Form 10-q extension | Aug 14, 2024 | Jun 30, 2024 |
| 8-K | Current report | Aug 7, 2024 | Aug 6, 2024 |
| DEF 14A | Proxy statement | Aug 1, 2024 | Sep 5, 2024 |
| PRER14A | Revised preliminary proxy statement | Jul 22, 2024 | — |
| 8-K |
Current report
Other events
|
Jul 15, 2024 | Jul 15, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 11, 2024 | Jul 11, 2024 |
| 424B4 | Prospectus | Jul 3, 2024 | — |
| EFFECT | Filing | Jul 1, 2024 | — |
| CORRESP | Letter to the SEC | Jun 28, 2024 | — |
| S-1/A | Amended registration statement | Jun 25, 2024 | — |
| PRER14A | Revised preliminary proxy statement | Jun 25, 2024 | — |
| CORRESP | Letter to the SEC | Jun 24, 2024 | — |
| 3 | Initial insider ownership | Jun 20, 2024 | Jun 10, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Jun 14, 2024 | Jun 10, 2024 |
| UPLOAD | Letter from the SEC | Jun 14, 2024 | — |
| CORRESP | Letter to the SEC | Jun 13, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jun 13, 2024 | Jun 8, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jun 10, 2024 | — |
| S-1/A | Amended registration statement | Jun 5, 2024 | — |
| PRER14A | Revised preliminary proxy statement | Jun 5, 2024 | — |
| 10-Q | Quarterly report | May 20, 2024 | Mar 31, 2024 |
| NT 10-Q | Notification of late filing | May 15, 2024 | Mar 31, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ONCO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cincinnati, OH
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1782107
- Former names
- Blue Water Biotech, Inc. (until Dec 18, 2023); Blue Water Vaccines Inc. (until Apr 20, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.